Low libido, decoded.

What's typically going on.

Desire is downstream of a lot of inputs. It depends on hormones produced by ovaries and adrenals, on the protein that carries those hormones around the blood, on thyroid hormone setting the metabolic backdrop, on iron and energy and sleep, and on the medications, life context and relationship dynamics that can dampen or amplify all of the above. Bloodwork cannot capture every layer of that. What it can do — and what a 15-minute primary care visit usually skips — is measure the inputs that are quietly running low.

In women, the most important androgen for libido is testosterone, but the number that matters is not the total. It is the free, unbound fraction — the portion not glued to sex hormone-binding globulin (SHBG). Total testosterone can sit comfortably mid-range while free testosterone is functionally low because SHBG is high. Two of the most common reasons SHBG runs high in U.S. women are combined oral contraception and oral estrogen therapy. Both reliably bind up free testosterone for the duration of use, and in some women for months after stopping. This is a measurable mechanism, not a feeling.

Estradiol and progesterone also matter, in cycle-context. In perimenopause, estradiol does not gracefully decline — it oscillates, and the swings themselves can produce vaginal dryness, sleep fragmentation and a quieter background hum of desire even before periods become irregular. Progesterone, produced after ovulation, declines earlier on average because anovulatory cycles become more common; its loss tends to show up as sleep disruption and increased anxiety, both of which sit on top of libido.

Thyroid hormone sets the metabolic floor everything else stands on. Low thyroid output, even subclinical, can flatten energy and desire in a way that women often attribute to stress for years before TSH moves out of range. Ferritin — stored iron — does something similar from the other direction: when stores fall below roughly 30 ng/mL, the cellular oxygen budget tightens, fatigue rises, and libido tends to fade from the foreground without making a sound about why.

None of this minimises the relational and contextual layer. New parenthood, caregiving, work load, sleep debt and SSRIs are all real drivers of desire change, and all of them can be true at the same time as a measurable biomarker pattern. The question worth answering with bloodwork is not "is it hormones or life" — it is "which measurable inputs are running low underneath whatever else is happening."

"Low libido in women is usually treated as a feelings problem first and a labs problem never. Both layers may be real. Only one of them gets measured by default."

The biomarkers most worth knowing.

You do not need every marker on this list to start. You need enough to triangulate. Read together by a qualified healthcare provider, the following panel catches most of the high-volume causes of persistent low libido in women 25–55.

None of these is useful as a single isolated number. They are useful as a panel, read in the context of your cycle, your medications and your symptoms. A clinician who reads a free testosterone in the bottom decile alongside high SHBG, fatigue and pill use is in a very different conversation from one who reads only "total testosterone normal."

Common patterns.

Three patterns show up repeatedly in editorial inbound on low libido. They do not exhaust the possibilities, and they are not diagnoses — they are pictures worth holding up to your own situation and raising with a qualified clinician.

The high-SHBG pattern

A woman in her late 20s or 30s on combined oral contraception notices desire has quietly faded over the past year or two. Total testosterone looks fine on labs. Free testosterone is in the bottom of the range or below. SHBG is meaningfully elevated. This is a mechanism, not a mystery — and worth a conversation about whether the current contraceptive is the right one, what the alternatives look like, and how SHBG and free testosterone respond after stopping.

The perimenopausal pattern

A woman between 38 and 52 notices libido is part of a wider cluster — cycle changes, 3 a.m. wake-ups, mood volatility second half of cycle, vaginal dryness arriving in the last year or two. Estradiol may be oscillating; progesterone is likely low in anovulatory cycles; free testosterone is gradually declining; FSH may be inching up. The right read here is the perimenopause hub, not a single hormone.

The depleted-floor pattern

A woman in her early 30s, often postpartum or recently postpartum, notices desire has not come back. Ferritin is below 30 ng/mL. TSH is upper-normal or rising. Vitamin D is below 30. She is sleeping less than six hours most nights. The libido symptom is sitting on top of a depleted floor — and the floor is the actually treatable layer.

What to ask your provider.

These are not a script. Your clinician will steer the conversation where it is most useful. They are a starting point that tends to widen the panel, sharpen the interpretation, and produce a clearer plan than the default 15-minute visit usually yields.

When to escalate vs when to track over time.

Most patterns on this page are worth a comfortable, planned conversation with a qualified healthcare provider — not an urgent visit. A few exceptions warrant a faster timeline.

Worth a planned conversation. Gradual decline in desire over months or years with no other red-flag symptoms, particularly if it overlaps with starting hormonal contraception, postpartum, perimenopausal cycle changes, or recent significant life stress. Bloodwork on a calm timeline; one re-test in three to six months if borderline.

Worth sooner. Libido change alongside new pelvic pain, pain with intercourse, new abnormal bleeding, breast discharge unrelated to breastfeeding, severe persistent fatigue, unexplained weight changes, drenching night sweats, or new low mood that resists lifestyle change. These belong with a clinician on a shorter timeline rather than waiting six months for a re-test.

Worth tracking, not panicking. A single borderline lab in someone who feels otherwise well is rarely the whole story. Trending the same markers six to twelve months apart, in the same lab and at the same time in the cycle where relevant, gives a more honest picture than one snapshot ever can.

Related Heme reading.

If libido is the entry point, these adjacent guides may help build a fuller picture — particularly if hormones, energy or perimenopausal patterns are part of the story.

• Testosterone in women, decoded — total vs free, why the free fraction is the one that matters, and where ranges sit.
• SHBG, in plain English — what it is, why oral estrogen raises it, and how it quietly lowers free testosterone.
• Estradiol, decoded — why timing within the cycle changes everything, and what to make of a perimenopausal swing.
• The perimenopause hub — what may begin a decade before the average age of menopause and what to test first.
• Fatigue, decoded — when desire fades because the floor is depleted, and how to tell.

Frequently asked.